4/22
09:11 am
pstv
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense [Yahoo! Finance]
Neutral
Report
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense [Yahoo! Finance]
4/22
07:15 am
pstv
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense [Yahoo! Finance]
Low
Report
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense [Yahoo! Finance]
4/22
07:00 am
pstv
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
High
Report
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
4/9
07:00 am
pstv
Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team
Medium
Report
Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team
3/27
08:00 am
pstv
Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference
Medium
Report
Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference
3/25
08:06 am
pstv
Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic [Yahoo! Finance]
Medium
Report
Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic [Yahoo! Finance]
3/25
08:00 am
pstv
Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic
Low
Report
Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic
3/11
07:35 am
pstv
Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases [Yahoo! Finance]
Medium
Report
Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases [Yahoo! Finance]
10/31/2023
04:05 pm
pstv
plus therapeutics, inc.
MISS
Report
6.6%
plus therapeutics, inc.
8/14/2023
04:05 pm
pstv
plus therapeutics, inc.
BEAT
Report
-2.8%
plus therapeutics, inc.
3/14
05:01 pm
pstv
Form 8-K PLUS THERAPEUTICS, INC. For: Mar 08
Medium
Report
Form 8-K PLUS THERAPEUTICS, INC. For: Mar 08
3/13
08:01 am
pstv
Form 8-K PLUS THERAPEUTICS, INC. For: Mar 12
Low
Report
Form 8-K PLUS THERAPEUTICS, INC. For: Mar 12
3/8
04:31 pm
pstv
Form S-1/A PLUS THERAPEUTICS, INC.
Medium
Report
Form S-1/A PLUS THERAPEUTICS, INC.
3/5
04:05 pm
pstv
Form 8-K PLUS THERAPEUTICS, INC. For: Mar 05
High
Report
Form 8-K PLUS THERAPEUTICS, INC. For: Mar 05
3/5
04:02 pm
pstv
Form 10-K PLUS THERAPEUTICS, INC. For: Dec 31
High
Report
Form 10-K PLUS THERAPEUTICS, INC. For: Dec 31
2/26
06:27 pm
pstv
Form 4 PLUS THERAPEUTICS, INC. For: Feb 22 Filed by: LaFrance Norman D.
Medium
Report
Form 4 PLUS THERAPEUTICS, INC. For: Feb 22 Filed by: LaFrance Norman D.
2/26
06:27 pm
pstv
Form 4 PLUS THERAPEUTICS, INC. For: Feb 22 Filed by: Clowes Howard
Medium
Report
Form 4 PLUS THERAPEUTICS, INC. For: Feb 22 Filed by: Clowes Howard
2/26
06:26 pm
pstv
Form 4 PLUS THERAPEUTICS, INC. For: Feb 22 Filed by: HEDRICK MARC H
Medium
Report
Form 4 PLUS THERAPEUTICS, INC. For: Feb 22 Filed by: HEDRICK MARC H
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register